Abstract
Recent researches demonstrated that N6-methyladenosine (m6A) is one of the most common internal modification of RNA in eukaryotic organisms. This is a dynamic and reversible modification, requiring methyltransferase-like 3 (METTL3)/methyltransferase-like14 (METTL14), fat mass and obesity-associated protein (FTO)/alk B homolog 5(ALKBH5), and YTH domain-containing proteins. The m6A modification of RNA influenced the downstream pathways, through regulating RNA degradation, mircoRNA (miRNA) processing, or translation. Recent emerging studies suggested that m6A was involved in the development and progression of multiple cancers. This article reviewed the expression pattern of m6A in solid tumors and the underlying mechanisms, in order for better understanding the tumorigenesis and development of human tumors and providing potential therapeutic strategies. Key words: N6-methyladenosine; Cancer; Methyltransferase; Demethylases; N6-methyladenosine-binding proteins
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
